Erik S Knudsen

32PUBLICATIONS
177CO-AUTHORS
Molecular targetsCancer cell biologyCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 02, 2026
Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance.

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Apr 27, 2026
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond.

|Apr 24, 2026
Cyclin E modulates vulnerability to CDC7 kinase inhibition.

|Apr 16, 2026
Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.

|Apr 10, 2026
Targeting Distinct Cell Cycle Nodes Overcomes KRAS/RAS Inhibitor Resistance.

Vishnu Kumarasamy, Jianxin Wang, Edwin Yau

Pageof 6

Frequent Collaborators

12 joint publications

Agnieszka K Witkiewicz

9 joint publications

Jianxin Wang

5 joint publications

Ethan V Abel

5 joint publications

Vishnu Kumarasamy